超液态碘化油联合药物洗脱微球经肝动脉化疗栓塞术治疗巴塞罗那B/C期肝细胞癌的效果分析

目的研究超液态碘化油联合药物洗脱微球经动脉化疗栓塞术 (TACE) 治疗巴塞罗那 (BCLC) B/C期肝细胞癌 (HCC) 的有效性和安全性。方法回顾性分析2016年5月-2018年9月苏州大学附属第一医院接受超液态碘化油联合药物洗脱微球栓塞治疗的51例BCLC B/C期HCC患者,比较治疗前和治疗后3 d、7 d、1个月的肝功能变化,详细记录不良反应及并发症发生情况,采用改良实体瘤疗效评价标准 (mRECIST) 评价术后1、3个月临床疗效。计量资料组间比较采用t检验。结果 51例患者均完成超选择栓塞,治疗病灶术后1个月疾病缓解率为70. 6%,疾病控制率为96. 1%; 3个月疾病缓解率...

Full description

Saved in:
Bibliographic Details
Published inLinchuang gandanbing zazhi Vol. 35; no. 7; pp. 1509 - 1513
Main Authors 唐浩桓, 朱晓黎, 王万胜, 李婉慈, 周林峰, 杜航
Format Journal Article
LanguageChinese
Published Changchun Journal of Clinical Hepatology 01.07.2019
苏州大学附属第一医院介入科,江苏苏州,215006
Subjects
Online AccessGet full text
ISSN1001-5256
2097-3497
DOI10.3969/j.issn.1001-5256.2019.07.018

Cover

Abstract 目的研究超液态碘化油联合药物洗脱微球经动脉化疗栓塞术 (TACE) 治疗巴塞罗那 (BCLC) B/C期肝细胞癌 (HCC) 的有效性和安全性。方法回顾性分析2016年5月-2018年9月苏州大学附属第一医院接受超液态碘化油联合药物洗脱微球栓塞治疗的51例BCLC B/C期HCC患者,比较治疗前和治疗后3 d、7 d、1个月的肝功能变化,详细记录不良反应及并发症发生情况,采用改良实体瘤疗效评价标准 (mRECIST) 评价术后1、3个月临床疗效。计量资料组间比较采用t检验。结果 51例患者均完成超选择栓塞,治疗病灶术后1个月疾病缓解率为70. 6%,疾病控制率为96. 1%; 3个月疾病缓解率为64. 0%,疾病控制率为88. 0%。术后3 d急性肝损伤发生率9. 8% (5/51) ,ALT、AST、TBil、Alb变化较术前有明显差异 (t值分别为-5. 454、-3. 997、-5. 346、7. 212,P值均<0. 001) ,术后1周ALT、TBil、Alb变化较术前有明显差异 (t值分别为-3. 177、-3. 665、3. 194,P值均<0. 05) 。术后1个月1级和2级不良反应...
AbstractList 目的研究超液态碘化油联合药物洗脱微球经动脉化疗栓塞术 (TACE) 治疗巴塞罗那 (BCLC) B/C期肝细胞癌 (HCC) 的有效性和安全性。方法回顾性分析2016年5月-2018年9月苏州大学附属第一医院接受超液态碘化油联合药物洗脱微球栓塞治疗的51例BCLC B/C期HCC患者,比较治疗前和治疗后3 d、7 d、1个月的肝功能变化,详细记录不良反应及并发症发生情况,采用改良实体瘤疗效评价标准 (mRECIST) 评价术后1、3个月临床疗效。计量资料组间比较采用t检验。结果 51例患者均完成超选择栓塞,治疗病灶术后1个月疾病缓解率为70. 6%,疾病控制率为96. 1%; 3个月疾病缓解率为64. 0%,疾病控制率为88. 0%。术后3 d急性肝损伤发生率9. 8% (5/51) ,ALT、AST、TBil、Alb变化较术前有明显差异 (t值分别为-5. 454、-3. 997、-5. 346、7. 212,P值均<0. 001) ,术后1周ALT、TBil、Alb变化较术前有明显差异 (t值分别为-3. 177、-3. 665、3. 194,P值均<0. 05) 。术后1个月1级和2级不良反应...
R735.7; 目的 研究超液态碘化油联合药物洗脱微球经动脉化疗栓塞术(TACE)治疗巴塞罗那(BCLC)B/C期肝细胞癌(HCC)的有效性和安全性.方法 回顾性分析2016年5月-2018年9月苏州大学附属第一医院接受超液态碘化油联合药物洗脱微球栓塞治疗的51例BCLC B/C期HCC患者,比较治疗前和治疗后3 d、7 d、1个月的肝功能变化,详细记录不良反应及并发症发生情况,采用改良实体瘤疗效评价标准(mRECIST)评价术后1、3个月临床疗效.计量资料组间比较采用t检验.结果 51例患者均完成超选择栓塞,治疗病灶术后1个月疾病缓解率为70.6%,疾病控制率为96.1%;3个月疾病缓解率为64.0%,疾病控制率为88.0%.术后3 d急性肝损伤发生率9.8%(5/51),ALT、AST、TBil、Alb变化较术前有明显差异(t值分别为-5.454、-3.997、-5.346、7.212,P值均<0.001),术后1周ALT、TBil、Alb变化较术前有明显差异(t值分别为-3.177、-3.665、3.194,P值均<0.05).术后1个月1级和2级不良反应发生率为68.6%(35/51),未出现肝衰竭、肝脓肿、胆汁瘤、消化道出血等并发症,1例患者术后61 d因肿瘤进展死于多脏器功能衰竭.结论 超液态碘化油联合药物洗脱微球TACE治疗BCLC B/C期HCC是安全有效的,远期疗效及生存获益有待于进一步观察.
Author 周林峰
李婉慈
杜航
王万胜
朱晓黎
唐浩桓
AuthorAffiliation 苏州大学附属第一医院介入科,江苏苏州,215006
AuthorAffiliation_xml – name: 苏州大学附属第一医院介入科,江苏苏州,215006
Author_xml – sequence: 1
  fullname: 唐浩桓
– sequence: 2
  fullname: 朱晓黎
– sequence: 3
  fullname: 王万胜
– sequence: 4
  fullname: 李婉慈
– sequence: 5
  fullname: 周林峰
– sequence: 6
  fullname: 杜航
BookMark eNpF0MtKw0AYBeBBFKyXp9CFm8SZTCbJLLV4A8GNrstMMpEWSdUoiisvVapULKitSq23jW4sllKRom-TmfgWRhRd_Rz4OAf-PtAd5AMBwDCCOqYWHc3p2TAMdAQh0ohBLN2AiOrQ1iFyukDKgNTWsEntbpD6M71gMAyzHBKELWoSKwU24_a-bDfl9o66v4hKFdl8i3fOonIxPm6owyfZqsaFl-jjWZX3VOck3r2Ojh7jwmEiVaUqb0-ju7qsNWSzk8TotZVE9V793H0YH03L2k3iVecg3qury5K6KsjzoqzXouKBrJcHQI_PlkIx-Hv7wcLkxHx6Wpudm5pJj81qywgjpHHsUyio8DgVBDLKqcuQyxl2he0hC1rI9IjHbAyhyV3HI0RwnzHiGNQxme_jfjDy07vBAp8Fi5lcfn01SBYzS-6ix7e2vt8GbWighA790OXV_Mq6CNf-LTZMiE2HOAR_ATT5muw
ClassificationCodes R735.7
ContentType Journal Article
Copyright 2019. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: 2019. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3969/j.issn.1001-5256.2019.07.018
DatabaseName ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Proquest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitle Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
DatabaseTitleList Publicly Available Content Database

Database_xml – sequence: 1
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitle_FL Clinical effect of transarterial chemoembolization with ultra-liquid iodized oil combined with drug-eluting beads in treatment of Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma
EISSN 2097-3497
EndPage 1513
ExternalDocumentID lcgdbzz201907021
GrantInformation_xml – fundername: 江苏省第五期"333高层次人才培养工程"科研项目BRA2017566); 国家自然科学基金面上项目; 江苏省科教兴卫工程医学重点人才课题
  funderid: 江苏省第五期"333高层次人才培养工程"科研项目BRA2017566); (81771945); (ZDRCA2016038)
GroupedDBID -05
3V.
5XA
5XF
7X7
7XB
88E
8FI
8FJ
8FK
92F
92I
ABDBF
ABJNI
ABUWG
ACGFS
ACUHS
AFKRA
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BENPR
CCEZO
CCPQU
CIEJG
CW9
DWQXO
EAD
EAP
EOJEC
ESX
FYUFA
K9.
M1P
OBODZ
OK1
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
RNS
TCJ
TGQ
U1G
U5O
2B.
4A8
93N
IPNFZ
PSX
RIG
ID FETCH-LOGICAL-p1311-b3f90e9edb9e50a9b9ca1cba3ce7d160614d5da73004bc8d55ebfaa582984aff3
IEDL.DBID BENPR
ISSN 1001-5256
IngestDate Thu May 29 04:06:08 EDT 2025
Tue Oct 07 07:27:30 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords 化学栓塞,治疗性
微球体
碘化油
癌,肝细胞
Language Chinese
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-p1311-b3f90e9edb9e50a9b9ca1cba3ce7d160614d5da73004bc8d55ebfaa582984aff3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
OpenAccessLink https://www.proquest.com/docview/3240348585?pq-origsite=%requestingapplication%&accountid=15518
PQID 3240348585
PQPubID 7350069
PageCount 5
ParticipantIDs wanfang_journals_lcgdbzz201907021
proquest_journals_3240348585
PublicationCentury 2000
PublicationDate 2019-07-01
PublicationDateYYYYMMDD 2019-07-01
PublicationDate_xml – month: 07
  year: 2019
  text: 2019-07-01
  day: 01
PublicationDecade 2010
PublicationPlace Changchun
PublicationPlace_xml – name: Changchun
PublicationTitle Linchuang gandanbing zazhi
PublicationTitle_FL Journal of Clinical Hepatology
PublicationYear 2019
Publisher Journal of Clinical Hepatology
苏州大学附属第一医院介入科,江苏苏州,215006
Publisher_xml – name: Journal of Clinical Hepatology
– name: 苏州大学附属第一医院介入科,江苏苏州,215006
SSID ssib051369456
ssib061082477
ssj0041983
ssib001103858
ssib053243598
ssib002264326
ssib038074677
Score 2.1887746
Snippet 目的研究超液态碘化油联合药物洗脱微球经动脉化疗栓塞术 (TACE) 治疗巴塞罗那 (BCLC) B/C期肝细胞癌 (HCC) 的有效性和安全性。方法回顾性分析2016年5月-2018年9月苏州大学...
R735.7; 目的 研究超液态碘化油联合药物洗脱微球经动脉化疗栓塞术(TACE)治疗巴塞罗那(BCLC)B/C期肝细胞癌(HCC)的有效性和安全性.方法 回顾性分析2016年5月-2018年9月苏州...
SourceID wanfang
proquest
SourceType Aggregation Database
StartPage 1509
SubjectTerms Chemoembolization
Disease control
Liver cancer
Liver failure
Remission (Medicine)
Surgery
Title 超液态碘化油联合药物洗脱微球经肝动脉化疗栓塞术治疗巴塞罗那B/C期肝细胞癌的效果分析
URI https://www.proquest.com/docview/3240348585
https://d.wanfangdata.com.cn/periodical/lcgdbzz201907021
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 2097-3497
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0041983
  issn: 1001-5256
  databaseCode: ABDBF
  dateStart: 20130401
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2097-3497
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib053243598
  issn: 1001-5256
  databaseCode: M~E
  dateStart: 19850101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2097-3497
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib061082477
  issn: 1001-5256
  databaseCode: 7X7
  dateStart: 20190101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 2097-3497
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib061082477
  issn: 1001-5256
  databaseCode: BENPR
  dateStart: 20190101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NaxNBFB_aBIsX8ROrNVTodc1-zOzuHESa2lAEg4iF3MrMzmyLSNraFktO_YgllYoBtVGJ8euiF4uhVCTof7Oz63_hzGbXpJceh3ksy-yb935v33u_B8AE4bruSUehOZxbGrRdrmHIuGZKXZYaZioaK1VtUbJnZuGdMioPgVLaC6PKKlObGBtqtuipf-T5mDgOqizWraVlTU2NUtnVdIQGSUYrsJsxxdgwyJqKGSsDsoXp0r37fYBg6MfYW1Qb6QCAUezrcIDgDRmWjWGfbQbJt1CUd-laYg_XjDs5e7YfyhC-V9Ivg3Qk0cQImFBxMbZx_mF8q2_831JlZTgmDjXcY_D21BNS8UllfsDPFc-CMwlAHZ_sadQ5MFRdOA9G7iYp-AtgPTp6Ko46YmMz_Pwm2NsXnV_R5qugUY-eH4S738RhM6r9CP58DxvbYfdFtPU-ePY1qu1KyXC_KT6-DD61RetAdLpyGfw8lMvwd_Pv1pdCfkq0Pkj5sLsTbbfDt3vhu5p4XRftVlDfEe3GRTBbnH4wNaMl4xu0JcXho1HLxzrHnFHMkU4wxR4xPEosjzvMsFUoyhAjijAfUs9lCHHqE4JcE7uQ-L51CWQqixV-GYwbzMHY16FHkAMhJhRhalFTd3zp44lpjIKx9Pzmkju4MtfXmFFwPTnT_u4jb57RalV9BKWTxpWTH3EVnFaivULdMZBZfbzGr0k4skpzYNgpOzmQnSzcLhRzicb9A6d__cY
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NTxNBFJ8gRPRi_Iwoak3wuHZnd2Z350CMIKQINMZAwq3O7M5ijCkoGLQngUqKwdhEpWpq_broRWJDMKaR_2Znl__Cme3Wlos3jpP5SHbmzXu_t_Pe7wEwQLmuu9JQaDbnpoYsh2sEeVwzpCxLCTMUjZWKtshamWl0cwbPdIHdVi6MCqts6cRYUXtzrvpHno6J45B6xbo2_0BTVaPU62qrhAZNSit4gzHFWJLYMc6fLEkXbmFw7IY87yuGMToyNZzRkioD2ryimtGY6ROdE-4xwrFOCSMuhS6jpsttD1rKY_KwRxWvO2Ku42HMmU8pdgziIOr7plz3EOhBJiLS-esZGsneut0GJFDfxxaj0lY7AJNie0cdhHIYmhZBbXYbLL9aUey12hLrOEacOdq0NQgSp5lCoEPpUmKrFwwoP5xYJH0v1iJX_3WpMDYSE5VCZx-cPrxE8z7Nz3bY1dHj4FgCiFPXmxJ8AnQV7p4EvZPJk_8p8DjaeSZ26uLpcvjlbbCxKeq_o-XXQbkUvdgK17-L7UpU_Bns_gjLq2HjZbTyIXj-LSquy5HhZkV8ehV8ronqlqg3ZDP4tS2b4Z_K3srXofSwqH6U48PGWrRaC99thO-L4k1J1KpBaU3UyqfB9IEc5BnQnZ_L87MgBT2bEF9HLsU2QoQyTJjJDN32JaagBuwD_a39yyV3fiHXltA-cDnZ03bvfXfWY4WCOgR1B-C5_y9xCRzJTE1O5CbGsuPnwVE1rRkk3A-6Fx8-4hckFFpkFxN5S4E7By3ifwGx5zpU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%B6%85%E6%B6%B2%E6%80%81%E7%A2%98%E5%8C%96%E6%B2%B9%E8%81%94%E5%90%88%E8%8D%AF%E7%89%A9%E6%B4%97%E8%84%B1%E5%BE%AE%E7%90%83%E7%BB%8F%E8%82%9D%E5%8A%A8%E8%84%89%E5%8C%96%E7%96%97%E6%A0%93%E5%A1%9E%E6%9C%AF%E6%B2%BB%E7%96%97%E5%B7%B4%E5%A1%9E%E7%BD%97%E9%82%A3B%2FC%E6%9C%9F%E8%82%9D%E7%BB%86%E8%83%9E%E7%99%8C%E7%9A%84%E6%95%88%E6%9E%9C%E5%88%86%E6%9E%90&rft.jtitle=Linchuang+gandanbing+zazhi&rft.au=%E5%94%90%E6%B5%A9%E6%A1%93&rft.au=%E6%9C%B1%E6%99%93%E9%BB%8E&rft.au=%E7%8E%8B%E4%B8%87%E8%83%9C&rft.au=%E6%9D%8E%E5%A9%89%E6%85%88&rft.date=2019-07-01&rft.pub=Journal+of+Clinical+Hepatology&rft.issn=1001-5256&rft.eissn=2097-3497&rft.volume=35&rft.issue=7&rft.spage=1509&rft_id=info:doi/10.3969%2Fj.issn.1001-5256.2019.07.018
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Flcgdbzz%2Flcgdbzz.jpg